John L. Villano, MD, PhD
3 clinical trials · Sponsor
◉ Watch John L. Villano, MD, PhD
| Record | Firm | Date |
|---|---|---|
| Pembro+Chemo in Brain Mets (NCT04964960) | John L. Villano, MD, PhD | 2022-05-19 |
| Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors (NCT03911557) | John L. Villano, MD, PhD | 2019-06-08 |
Track John L. Villano, MD, PhD automatically
Every clearance here is in the API, with alerts when new ones post.